Comparison · NCT03913221-deaths
Low Dose Caffeine (5 mg/kg) vs High Dose Caffeine (10 mg/kg): deaths from any cause
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Low Dose Caffeine (5 mg/kg) vs High Dose Caffeine (10 mg/kg): deaths from any cause. Trial comparisons, record NCT03913221-deaths. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03913221-deaths
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.111 | 0.0199 | 0.435 | wilson | |
| Risk in group 2 | 0.125 | 0.0224 | 0.471 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0139 | -0.372 | 0.326 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.889 | 0.0658 | 12 | log | |
| Odds ratio, group 1 over group 2 | 0.875 | 0.0457 | 16.7 | log | |
| Number needed to treat, for one fewer death from any cause on Low Dose Caffeine (5 mg/kg) than on High Dose Caffeine (10 mg/kg) | 72 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Low Dose Caffeine (5 mg/kg) | Within 24 hours of delivery, participants will receive low dose administration of Caffeine citrate.~Caffeine Citrate 5 mg/kg: Loading dose of caffeine 20 mg/kg IV followed by two daily doses of 5 mg/kg IV. | 1 | 9 | EG000 |
| Group 2 | High Dose Caffeine (10 mg/kg) | Within 24 hours of delivery, participants will receive high dose administration of Caffeine citrate.~Caffeine Citrate 10 mg/kg: Loading dose of caffeine 20 mg/kg IV followed by two daily doses of 10 mg/kg IV. | 1 | 8 | EG001 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, all-cause mortality
- Time frame
- From the first dose of study intervention through 7 days after the last dose of study intervention, approximately 10 days.
Source ClinicalTrials.gov
Trial
- Title
- Caffeine for Hypoxic-Ischemic Encephalopathy
- NCT number
- NCT03913221
- Phases
- PHASE1
- Conditions
- Hypoxic-Ischemic Encephalopathy
- Interventions
- Caffeine Citrate 5 mg/kg, Caffeine Citrate 10 mg/kg
- Lead sponsor
- University of North Carolina, Chapel Hill
- Results first posted
- 2024-09-19
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03913221?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03913221-deaths